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1. Introduction
1.1. Estrogens and phytoestrogens
Estrogens are a group of steroid hormones that control the development and maintenance of an
individual’s feminine characteristics. They regulate many physiological processes, including normal
cell growth, development, and tissue-specific gene regulation in the reproductive tract and in the
central nervous and skeletal systems. Estrogens also influence the pathological processes of
hormone-dependent diseases, such as breast, endometrial, and ovarian cancers, as well as
osteoporosis (Couse & Korach 1999). The naturally occurring estrogens, 17β-estradiol (E2), estrone
(E1) and estriol (E3), are C18 steroids derived from cholesterol (Gruber et al. 2002). The most potent
among them is E2, while estrone and estriol are, although high-affinity ligands, much weaker
agonists on estrogen receptors (ERs) (Heldring et al. 2007). Estrogens are produced primarily in the
theca and granulosa cells of the ovaries and, during pregnancy, in the placenta. Some estrogens are
produced in smaller amounts by other tissues such as the liver, adrenal glands, breasts and adipose
tissue (Gruber et al. 2002).
Phytoestrogens, also called dietary estrogens, are a broad group of plant-derived compounds of
nonsteroidal structure that are structurally and/or functionally similar to mammalian estrogens and
their active metabolites (Patisaul & Jefferson 2010; Setchell 1998) Phytoestrogens exert their
effects primarily through binding to estrogen receptors, wherefore, they can act as estrogen agonists
or antagonists. The key structural elements crucial for the estradiol-like effects are: (1) the phenolic
ring that is indispensable for binding to estrogen receptors, (2) the ring of isoflavones mimicking a
ring of estrogens at the receptors binding site, (3) low molecular weight similar to estrogens
(MW=272), (4) distance between two hydroxyl groups at the isoflavones nucleus similar to that
occurring in estradiol, (5) optimal hydroxylation pattern (Kariyil 2010). Phytoestrogens were first
observed in 1926 but it was unknown if they could have any effect in human or animal metabolism.
In the 1940s it was noticed for the first time that red clover (a phytoestrogens-rich plant) pastures
had effects on the fertility of grazing sheep (Murkies et al. 1998). Dietary estrogens are weakly
estrogenic (10- 2 to 10-3 -fold) when compared with estradiol (Setchell 1998).  In vitro assays have
found that, although most phytoestrogens, bind both ERα and ERβ, and activate ER-dependent gene
transcription through both ER subtypes, they generally have a higher relative binding affinity for
ERβ than Erα (Kuiper et al. 1997; Patisaul & Jefferson 2010). The four major classes of
phytoestrogens are isoflavones,  lignans, stilbenes and coumestans (Mense et al. 2008). They are
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found in a wide variety of plants, including soybean and other legumes, flaxseed, alfalfa,
pomegranate, wheat, oats, hops. Today, daidzein and genistein are the two most well characterized
phytoestrogens and human exposure to these compounds occurs primarily through the consumption
of soy-based food and beverage products. Possible effects of phytoestrogens have been implicated
in the etiology of hormone-dependent cancers, cardiovascular diseases, osteoporosis, menopausal
symptoms, male infertility, obesity and type-2 diabetes (Kariyil 2010). These health benefits have
been supported by lower incidence of hormone-dependent diseases in Asian populations than in
Western populations. Epidemiological evidence suggest that Asian women have a 3-fold lower
breast cancer risk than women in the United States, independent of body weight (Mense et al.
2008). Apart from that, Asian populations have historically had lower rates of cardiovascular
diseases, diabetes, obesity, menopausal symptoms, colorectal and prostate cancer (Adlercreutz &
Mazur 1997). The explanation for that comes from high soy consumption, which is a cornerstone of
the traditional Asian diet (Patisaul & Jefferson 2010). More specifically, in East and Southeast Asia,
the average daily intake of phytoestrogens is estimated to be between 20 and 50 mg. In contrast, the
typical diet of an adult in the United States contains only 0.15–3 mg phytoestrogens per day, and in
Europe the average daily phytoestrogen consumption is estimated to be even lower, falling between
0.49 and 1 mg (Adlercreutz & Mazur 1997; Sirtori et al. 2005). The effect produced by
phytoestrogens can depend on the dose of the phytoestrogen. Phytoestrogens acting as estrogen
mimics may affect the production and/or the breakdown of estrogen by the body, as well as the
levels of estrogen carried in the bloodstream. Phytoestrogens acting differently from estrogen may
affect communication pathways between cells, prevent the formation of blood vessels to tumors or
alter processes involved in the processing of DNA for cell multiplication (Kariyil 2010).
1.2. Mondia whitei
Mondia whitei (Hook.f.) Skeels is an aromatic plant of  Periplocaceae family which occurs
throughout tropical Africa, from Senegal east to southern Sudan, and throughout most of Central,
East and southern Africa to South Africa (Schmelzer & Gurib-Fakim 2013). It is commonly known
as White’s ginger, Limte, Nkang Bongo, Yang, La Racine, Gondolosi (Watcho et al. 2006; Lampiao
2008). Mondia whitei is a perennial, woody, rather robust and vigorous climber that grows from a
large tuberous rootstock. The roots are aromatic and apparently taste like ginger or liquorice and
have an aroma reminding of vanilla (Okon et al. 2012) The plant is medicinally used throughout its
distribution area. Its roots are used as a traditional remedy to treat various conditions and diseases,
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including urinary tract infection, jaundice, headache, gastrointestinal disorders and diarrhea,
gonorrhea, postpartum bleeding, pediatric asthma, vomiting, malaria, but the most commonly cited
use is as an aphrodisiac (Schmelzer & Gurib-Fakim 2013; Okon et al. 2012; Watcho et al. 2007)
Usually the fresh or dried roots or the root bark are chewed for this purpose (Schmelzer & Gurib-
Fakim 2013).  
Scientific research conducted so far on this plant involves evaluation of antibacterial and anti-
inflammatory activity, antidepressant-like activity, reproductive activity and effects on the hearth
(Schmelzer & Gurib-Fakim 2013; Okon et al. 2012; Watcho et al. 2007). Phytochemically, Mondia
whitei was demonstrated to contain steroids, triterpenes (a mixture of amyrine α- and β-acetate,
lupeol, β-sitosterol, and β-sitosterol glucoside) and aromatic compounds (2-hydroxy-4-
methoxybenzaldehyde, 3 -hydroxy-4-methoxybenza ldehyde , and 4 -hydroxy-3-
methoxybenzaldehyde), glucose, and polyholosides (Watcho et al. 2006). Other constituents include
zinc, iron, calcium, magnesium and vitamins (A, D and K) (Patnam et al. 2005). Interestingly,
Watcho et al. (2001 and 2004) report different effects of Mondia whitei aqueous extract in adult
male rats depending on the treatment duration: a short-term treatment (8 days) results in the
increase in serum and intratesticular testosterone levels, whereas a long-term treatment (55 days)
has inhibitory effects on spermatogenesis and reduces fertility. Overall, Mondia whitei had been
mostly studied in terms of male sexual stimulant, but more research is necessary to elucidate the
compounds responsible for the activity and also investigate other pharmacological effects.
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Figure 1. Mondia whitei
 A) flowers (photography); B) 1-flowering brunch, 2-fruits (draft)
Source: Schmelzer & Gurib-Fakim, 2013.
1.3. Estrogen receptors
The biological actions of estrogens are mediated by binding to estrogen receptors which belong to
the nuclear receptor superfamily, a family of ligand-regulated transcription factors (Matthews &
Gustafsson 2003). The existence of the receptor molecule that could bind 17β-estradiol was first
demonstrated by Jensen and Jacobsen in the late 1950s (Dahlman-Wright et al. 2006). The first ER
was cloned in 1986.  Until 1995, it was assumed that there was only one ER and that it was
responsible for mediating all of the physiological and pharmacological effects of natural and
synthetic estrogens and anti-estrogens. However, in 1995, a second ER, ERβ, was cloned from a rat
prostate cDNA library. The first ER was then renamed to ERα (Nilsson et al. 2001). The two ER
subtypes, ERα and ERβ, are products of distinct genes on different chromosomes. ERα is located at
chromosomal locus 6q25.1, whereas ERβ is found at position 14q22–24 (Matthews & Gustafsson
2003; Gruber et al. 2002) Several ERα and ERβ splicing variants have been described, but whether
all transcripts are expressed as functional proteins and have biological functions remains unclear
(Matthews & Gustafsson 2003).
ERα and ERβ can be detected in a broad spectrum of tissues. In some organs, both receptor
subtypes are expressed at similar levels, whereas in others, one or the other subtype predominates.
In addition, both receptor subtypes may be present in the same tissue but in different cell type
(Dahlman-Wright et al. 2006). ERα is expressed primarily in the uterus, liver, kidney, and heart,
whereas ERβ is expressed primarily in the ovary, prostate, lung, gastrointestinal tract, bladder,
hematopoietic and central nervous systems. ERα and ERβ are, however, co-expressed in a number
of tissues including the mammary gland, epididymis, thyroid, adrenal, bone, and certain regions of
the brain (Matthews & Gustafsson 2003). There has been suggested a, so-called, “Ying Yang”
relationship between  ERα and ERβ whereby in the presence of ERα, ERβ inhibits ERα-mediated
gene transcription and in the absence of ERα, ERβ can partially replace ERα (Lindberg et al. 2003).
ERα and ERβ contain the evolutionarily conserved structural and functional domains typical of
nuclear receptor family members (Matthews & Gustafsson 2003). They are composed of six
domains named A-F from N- to C- terminus: (1) the N-terminal A/B domain which modulates
transcription in gene- and cell- specific manner through Activation Function 1 (AF-1); (2)  highly
conserved C region harboring the DNA-binding domain (DBD); (3)  D domain which serves as a
linker peptide between the DBD and the ligand-binding domain (LBD); (4) E domain (LBD) which
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contains Activation Function 2 (AF-2) and (5) F domain that plays role in distinguishing estrogen
agonists versus antagonists (Klinge 2001; Ruff et al. 2000). (Fig. 2).                     
The most conserved region between ERα and ERβ is the DBD featuring two zinc fingers (CI and
CII) with which  receptor interacts directly with the DNA helix (Kuiper et al. 1997; Klinge 2001).
The amino acid sequence identity between ERα and ERβ in this domain is approximately 97%,
while the amino acid sequence of the P-box (a motif within DBD critical for receptor-DNA
recognition and specificity) is identical between the two receptors (Matthews & Gustafsson 2003;
Dahlman-Wright et al. 2006). Thus ERα and ERβ can be expected to bind to various estrogen
response elements (EREs) with similar specificity and affinity. The ligand-binding domains are also
conserved with approximately 56% homology in amino acid sequence (Dahlman-Wright et al.
2006). Thus both receptor subtypes exhibit similar affinities for E2 and most other ligands (Barkhem
et al. 1998). Nevertheless, there are a number of ligands displaying receptor-selective affinity
(Kuiper et al. 1997).
The transactivating functions of ERα and ERβ are mediated by two transcription activation
functions that allow the receptors to stimulate the transcription of estrogen-regulated genes: the
constitutively active AF-1 located in N-terminal domain and the ligand-dependent AF-2 located in
the C-terminal domain of the receptor protein (Klinge 2001; Matthews & Gustafsson 2003). A
comparison of the AF-1 domains of the two ERs has revealed that this domain is very active in ERα
on a variety of estrogen responsive promoters, but under identical conditions, the activity of AF-1 in
ERβ is minimal (Barkhem et al. 1998). Furthermore, these two receptors exhibit distinctive
responses to the synthetic anti-estrogens tamoxifen and raloxifene. These ligands are partial ER
agonists for ERα but act as pure ER antagonists for ERβ. The differences between the N-terminal
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Figure 2. Schematic representation of the functional domain organization of estrogen receptors.
 Domains from N- to C- terminus are: the A/B domain at the NH2 terminus which contains the AF-1
site, a highly conserved DBD consisting of the C domain, a hinge region D, the LBD (domain E)
which contains AF-2 and C-terminal F domain. Presented scheme applies to both ER subtypes. 
Adapted from: Ruff et al. 2000.
regions of the ERs, in terms of poorly homologous amino acid sequence (18%), have been
suggested as a possible explanation for their diversity of responsiveness to several ligands
(Matthews & Gustafsson 2003; Dahlman-Wright et al. 2006).
Agonists and antagonists bind at the same site within the core of the LBD, but demonstrate different
binding modes (Brzozowski et al. 1997). Crystallographic studies with the LBDs of ERα and ERβ
revealed that the AF-2 interaction surface is composed of amino acids in helix 3, 4, 5, and 12 and
that the position of helix 12 is altered by binding of ligands (Nilsson et al. 2001). When the ERα
LBD is complexed with agonists such as E2, helix 12 is positioned over the ligand binding
pocket and forms an interaction surface for the recruitment of co-activators. In contrast, when either
the ERα- or ERβ-LBDs are complexed with antagonists, helix 12 is displaced from its agonist
position and occupies the hydrophobic groove formed by helices 3, 4, and 5, causing helix 12 to
disrupt the co-activator interaction surface (Matthews & Gustafsson 2003; Brzozowski et al. 1997).
It is evident that different ligands induce different receptor conformations and that the positioning
of helix 12 is the key event that permits discrimination between estrogen agonists and antagonists
(Nilsson et al. 2001).
For several years it was thought that the only mechanism through which estrogens affected
transcription of E2-sensitive genes was so-called classical ligand-dependent model where activated
ER directly bind to EREs, specific DNA sequences found in the regulatory regions of estrogen-
responsive genes (Hall et al. 2001; Nilsson et al. 2001). Today, there are known three other ER
pathways through which are biological effects of E2 mediated. The first one is ligand-independent
activation of ER where growth factors or cyclic adenosine monophosphate activate intracellular
kinase pathways, leading to phosphorylation and activation of ER at ERE-containing promoters in a
ligand-independent manner. The second ER signaling mechanism is ERE-independent model where
ligand-bound ERs interact with other transcription factor complexes like Fos/Jun (AP-1-responsive
elements)  or SP-1 (GC-rich SP-1 motifs)  and influence transcription of genes whose promoters do
not harbor EREs (Heldring et al. 2007). The last known mechanism is cell-surface (non-genomic)
signaling in which E2 activates a putative membrane associated binding site, possibly a form of ER
linked to intracellular signal transduction pathways that generate rapid tissue responses (Hall et al
2001).
The classic pathway, where ERs are activated in a ligand-dependent manner, is the relevant
signaling pathway for this study and will be, therefore, described in detail. This model states that, in
the absence of hormone, ER is sequestered in a multiprotein complex with  chaperones that stabilize
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the receptor in an unactivated state or mask the DBD of the receptor (Gruber et al. 2002; Hall et al.
2001; Smith & Toft 1993). The exact location of ERs is not entirely clear. They are probably in an
equilibrium distribution between the cytoplasm and the nucleus and the equilibrium is then shifted
after ligand binding (Gruber et al. 2002). In response to ligand binding, ER undergoes
conformational changes, termed “activation”, accompanied by dissociation of hsp90, hsp70 and
other receptor-associated proteins (Klinge 2001) (Fig. 2). The ligand–receptor complex then moves
to the nucleus where two ER dimerize forming homo- (α/α, β/β) or heterodimers (α/β) (Gruber et al.
2002; Matthews & Gustafsson 2003). Liganded ER dimers further bind directly to specific DNA
sequences called estrogen response elements (EREs), which are cis-acting enhancers located within
the regulatory regions of target genes (Hallet al. 2001). The ERE was first identified by aligning
sequences with shared homologies in the 5´flanking regions of the estrogen-regulated vitellogenin
genes A1, A2, B1 and B2 from Xenopus laevis and chicken and the chicken apo-VLDLII gene
(Walker et al. 1984). Many genes that contain EREs have been identified and a 13 bp palindromic
inverted repeat 5′-GGTCAnnnTGACC-3′ (n = any nucleotide) was found to be the minimal
consensus ERE sequence (Klein-Hitpass et al. 1988). However, only a handful of the most highly
estrogen-responsive genes contain perfect consensus EREs. Many genes have been found to contain
non-palindromic ERE sequences which vary from the consensus by one or more nucleotides
(Driscoll et al. 1998) . ER dimer binding to ERE occurs by interaction  of three specific amino acids
within the P box of zinc finger CI in the major groove of DNA helix in a sequence-specific manner.
Therefore, each ER monomer is bound to DNA in the major groove with the ER dimer located
predominantly on one face of DNA helix. The DNA-bound receptors contact the general
transcription apparatus either directly or indirectly via cofactor proteins. Examples of ER
coactivators include, members of the p160/SRC (Steroid Receptor Coactivator) family:
SRC1/NCoA1 (Nuclear Receptor Coactivator-1); NCoA2; NCoA3/AIB1/TRAM1/RAC3; the
cointegrators: CBP (CREB-Binding Protein) and p300; and the family of CITED (CBP/P300-
Interacting Transactivator, With Glu/Asp-Rich Carboxy-Terminal Domain) proteins (Moggs &
Orphanides 2001). It is generally accepted that the ER-coactivator interactions stabilize the
formation of a transcription preinitiation complex and facilitate the necessary disruption of
chromatin at the ERE (Fig. 3). Depending on the cell and promoter context, the DNA-bound
receptor exerts either a positive or negative effect on expression of the downstream target gene.
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1.4. Fulvestrant
Fulvestrant (Faslodex®; Astrazeneca) is an estrogen receptor antagonist with no agonistic effects. It 
down-regulates cellular levels of the ER and blocks both AF-1 and AF-2 transcription-activating 
functions of ER (Howell et al. 2005; Wakeling et al. 1991). It is used in the treatment of ER-
positive advanced breast cancer in postmenopausal women. The requisite for its development 
emerged from serious side effects of tamoxifen, which had been previously used in the therapy of 
breast cancer (Jaiyesimi et al. 1995). Tamoxifen is a selective estrogen receptor modulator (SERM),
meaning that it exhibits tissue-specific activity. It acts as an antagonist in breast, but as agonist in 
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Figure 3. Classic Pathway of Estrogen Signal
Transduction.
When an estrogen molecule binds to ER and the
receptor dissociates from its cytoplasmic chaperones.
The ligand–receptor complex then moves to the
nucleus, where it binds to DNA and initiates
transcription. Transcription is catalyzed by RNA
polymerase II (POL II) and requires the assembly of
various proteins, including the TATA-box–binding
protein (TBP) and other associated factors at a TATA
box. Other transcription factors join thereafter,
completing the preinitiation complex. Activated
estrogen receptors interact with several proteins, such
as the 160-kD steroidreceptor coactivator protein
(P160) and p300–cyclic AMP response-element–
binding protein (CBP). This complex binds to the
estrogen response element (ERE) through the DNA-
binding domain (DBD) of the receptor and stimulates
transcription; proposed mechanisms of stimulation
include stabilization of the preinitiation complex,
chromatin remodeling, and interaction with other
transcription factors.
Source: Hall et al. 2001.
bone and uterus (Deroo & Korach 2006). With long-term use, tamoxifen’s estrogen-like properties 
are associated with two- to three-fold increase in the risk of developing endometrial cancer 
(Jaiyesimi et al. 1995).
1.5. Cell line
This study was conducted using U2OS-ERα and U2OS-ERβ cell lines, which are characterized by
inducible expression of  ERα and ERβ, respectively. These two cell lines were obtained from
Monroe et al. who developed them from the ER-negative U2OS parental cell line using T-RExTM
System by Invitrogen, which will be further described. U2OS cell line is a human osteosarcoma cell
line derived in 1964 from a moderately differentiated sarcoma of the tibia of a 15 year old girl.
Cells exhibit epithelial adherent morphology (General cell collection: U-2 OS) The U2OS cell line
was chosen mainly due to its bone-forming osteoblasts (OB)-like properties, their rapid growth,
ease of transfection, and the lack of detectable endogenous ER expression (Monroe et al. 2003).
T-RExT M System by Invitrogen was used to generate cell lines which stably express equivalent
levels of either ERα or ERβ, from  ER-negative parental cell line. This system is a tetracycline-
regulated mammalian expression system that uses regulatory elements from the E. coli Tn10-
encoded tetracycline (Tet) resistance operon (Hillen & Berens 1994). The system utilizes two
vectors: (1)  pcDNA6/TRß vector, a regulatory plasmid which encodes the Tet repressor (TetR)
under the control of the human cytomegalovirus immediate-early (CMV) promoter and (2) an
inducible expression plasmid, pcDNA4/TOß which contains gene of interest (ERα or ERβ) under
the control of the strong human CMV promoter and two tetracycline operator 2 (TetO2) sites. Both
plasmids were stably transfected into ER-negative U2OS cells by Monroe et al. In the absence of
doxycycline (Dox), which is a Tet analog, the Tet repressor forms a homodimer that binds with
extremely high affinity to each TetO2 sequence in the promoter of the inducible expression vector
and thus silences transcription of the cloned gene (ERα or ERβ gene). Upon addition, Dox binds
with high affinity to each Tet repressor homodimer in a 1:1 stoichiometry and causes a
conformational change in the repressor that renders it unable to bind to the Tet operator. The Tet
repressor-Dox complex then dissociates from the Tet operator and allows induction of transcription
from the gene of interest (ERα or ERβ gene) (T-RExTM System - trexsystem_man.pdf)(Figure 4).
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1.6. Transfection
Transfection is the process by which nucleic acids are introduced into mammalian cells, stably or
transiently. In transient transfection, the introduced nucleic acid exists in the cell only for a limited
period of time and is not integrated into the genome. As such, transiently transfected genetic
material is not passed from generation to generation during cell division, and it can be lost by
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ERα or Erβ gene
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Figure 4. The mechanism and components of the T-RExTM System.
TetR protein is expressed from pcDNA6/TR in cultured cells. TetR
homodimers bind to TetO2  sequences in the inducible expression
vector, repressing transcription of the gene of interest (ERα and ERβ
gene, respectively). Upon addition, Dox binds to TetR homodimers.
Binding of Dox to TetR causes conformational change in TetR,
release from the TetO2 sequences and induction of transcription from
the  gene of interest (ERα or ERβ gene). Adapted from:T-REx™-
System Manual Invitrogen.
environmental factors or diluted out during cell division. Stable transfection introduces DNA into
cells long-term. Stably transfected cells pass the introduced DNA to their progeny, typically
because the transfected DNA has been incorporated into the genome, but sometimes via stable
inheritance of nongenomic DNA. Common transfection methods are electroporation, calcium
phosphate co-precipitation and cationic lipid mediated transfection (https://www.thermofisher.com).
In this study, cationic lipid mediated transfection method was applied using Attractene Transfection
Reagent by QIAGEN. Attractene Reagent is a nonliposomal lipid that forms a complex with DNA
and enters the cell through endocytosis. It enables rapid fast-forward DNA transfection, meaning
that cells are seeded and transfected at the same day. This is quicker, saves labor, and increases
experimental flexibility compared to protocols where cells are seeded the day before transfection
(https://www.qiagen.com).
1.7. Aims and objectives
The aim of this study was to evaluate a tropical African plant, Mondia whitei, for estrogenic and
anti-estrogenic activity. For this purpose, methanol extract of the plant and 12 different fractions of
the extract would be examined in  U2OS-ERα and U2OS-ERβ cells.  The principal investigation
method would be estrogen receptor subtype specific transactivation assays. In addition, cytotoxicity
of all  herbal treatments would be verified using MTT assay. This study was conducted as a part of
the “Angola Project” which aims to better, science based understanding of traditionally known
medicinal uses of plants. The presented results were obtained in collaboration with the Instituto
Nacional da Biodiversidade e Áreas de Conservação (INBAC) of the Ministério do Ambiente da
República de Angola. 
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2. Materials and methods
2.1. Materials
Table 1.  List of used chemicals
Chemical Manufacturer
0.9% saline solution TU Dresden
17 β-Estradiol Sigma
4% CuSO4 x 5H2O solution TU Dresden
Ampicilin solution (50 mg/ml) TU Dresden
BC Assay Reagent A Uptima
Blasticidin S (5 mg/ml) Invitrogen
BSA (1 mg/ml) Applichem
DCC Biowest
DMEM/F12 Biowest
DMSO Sigma
Doxycycline solution (10 μg/ml) TU Dresden
Ethanol TU Dresden
FCS Biowest
MTT powder Sigma
PBS TU Dresden
Trypsin/EDTA (10x) Biochrom
Zeocin (100 mg/ml) Invitrogen
Table 2. Overview of used media and solutions
Medium/solution Composition
1% DCC-supplemented medium
99 ml DMEM/F12
1 ml DCC (100%)
5% DCC-supplemented medium
190 ml DMEM/F12
10 ml DCC (100%)
10% FCS-supplemented medium
180 ml DMEM/F12
20 ml FCS (100%)
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DMEM/F12
Provided by manufacturer in 1:1 ratio, already 
contains penicilin and steptomycin
Freezing medium
14 ml 10% FCS-supplemented medium
4 ml FCS (100%)
2 ml DMSO
Luria Bertani medium supplemented with 
Ampicilin
50 ml previously prepared Luria Bertani 
medium
0.05 ml Ampicilin (50 mg/ml)
MTT solubilization solution
100 ml Isopropanol
0.333 ml HCl (12N)
MTT working solution
50 mg MTT formazan powder dissolved in 10 
ml PBS
Selective culture medium:
10% FCS-supplemented medium + Blastidicin S
(2.5 mg/l) + Zeocin (250 mg/l)
50 ml 10% FCS-supplemented medium
0.025 ml Blasticidin S (5 mg/ml)
0.125 Zeocin (100 mg/ml)
Table 3. List of used kits
Kit Manufacturer
Attractene Transfection Reagent QIAGEN
Luciferase Assay System Promega
Plasmid plus Midi Kit QIAGEN
Table 4. Overview of used equipment
Equipment Manufacturer
Spectrophotometer Specord 200 Analytik Jena
Analysis software WinASPECT Analytik Jena
NanoDrop 1000 spectrophotometer Thermo Scientific
Analysis software NanoDrop 1000 Thermo Scientific
Microplate Reader Infinite F200 Tecan
Analysis software Magellan Tecan
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Cell culture and Mondia whitei extracts and fractions
U2OS-ERα and U2OS-ERβ cell lines were provided by Monroe et al. working group. Methanol
extract of Mondia whitei and its fractions were obtained from Prof. Stuppner working group
(University of Innsbruck, Institute of Pharmay/Pharmacognosy). Powdered plant materials were
extracted by methanol after defatting with petroleum ether and the extract was chromatographed
using silica gel. HPLC elution profiles were used to identify fractions with similar profiles selected
for the in vitro tests.  Herbal extract and its fractions were then we diluted in DMSO.
2.2. Methods
2.2.1. Cell culture work
Thawing the cryopreserved U2OS-ERα and U2OS-ERβ cells
The U2OS-ERα and U2OS-ERβ cells used in this work had previously been stored by freezing in
liquid nitrogen. Cell aliquots of both cell lines were taken out from cryogenic tank and warmed up
at room temperature until they were completely thawed. Such cell aliquots were then transferred
into centrifuge tubes with 5 ml selective culture media and centrifuged at 175 x g and room
temperature for 5 minutes. Following centrifugation, supernatant was discarded while pellet was
resuspended in 1 ml selective media and transferred into 25 cm2 cell culture flasks with previously
added 3 ml selective culture media. Cells were thus incubated for ca. 24 hours in the incubator.
Cultivation of U2OS-ERα and U2OS-ERβ cell lines
All the cell culture experiments were conducted in Class II biosafety cabinets. The cells were
maintained in a 37 °C incubator with a humidified atmosphere of 5% CO2  in air. All the used
growth media were stored in refrigerator at 6 °C and prior to use were warmed shortly in a water
bath at 37 °C. After thawing, both cell lines were first plated into 25 cm2 cell culture flasks and
following 24 hours incubation, were passaged into 75 cm2 cell culture flasks in which they were
further maintained.  Selective medium was first used for cell cultivation following thawing. After
few days, medium was changed to 10% FCS-medium, while few days prior to and during
transactivation assays, cells were  cultured in 5% DCC-medium.
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Medium change and subculturing
The medium was changed approximately every second day in order to keep the cells healthy by
providing fresh nutrients. The procedure involved removal of old medium using sterile glass pipette
and addition of 10 ml fresh medium per 75 cm2 cell culture flask. In cases when medium was
changed from 10% FCS-medium to 5% DCC-medium, cells were rinsed twice with 5 ml PBS prior
to addition of new medium.
When ca. 90% confluency had been reached, cells were subcultured (i.e., passaged). For that
purpose, old medium was removed and cells were rinsed with 5 ml of PBS. Cells were then
enzymatically detached from the surface of culture flask by addition of 3 ml of PBS and 330 μl of
10x Trypsin/EDTA and incubation for 5 minutes in the incubator. Following incubation, cells were
observed under the microscope to check if most of the cells had detached. In few cases, only small
amount of cells had detached, so the incubation was prolonged for 2 minutes which resulted in
larger amount of detached cells. After that, detachment of the cells was stopped by addition of 2 ml
of growth medium. The cell suspension was then transferred into 15 ml centrifuge tube and
centrifuged at 175 x g and room temperature for 5 minutes. Following centrifugation, supernatant
was discarded while pellet was resuspended in 1 ml growth medium. The appropriate amount of
thus obtained cell suspension was then transferred into 75 cm2 cell culture flasks with previously
added 10 ml culture medium. Cells were passaged in different amounts, from ¼ to 1/15 ratio,
depending on the time point and growth rate. When passaged in ¼ ratio it took 2-3 days to reach
90% confluency, while 1/15 ratio needed 6-7 days to reach 90% confluency. It has been observed that
U2OS-ERβ cells grow slightly faster than  U2OS-ERα cells.
Freezing U2OS-ERα and U2OS-ERβ cell lines
Since the highest recommended passage number for both cell lines is ca. 30 before occurrence of
more genomic abnormalities, it was necessary to freeze the cells with lower passage number in
multiple aliquots in liquid nitrogen to ensure cells for further experiments. The procedure was as
same as for cell subculturing until the step following centrifugation, with the exception that cell
detachment was stopped by addition of 2 ml freezing medium. After centrifugation, supernatant was
discarded and pellet was resuspended in 1 ml freezing medium. The cell suspension was then
transferred into cryogenic storage vials that were placed in a freezing container containing isopropyl
alcohol.  A freezing container was stored at -80°C. Later the cell aliquots were transferred into the
fluid nitrogen tank for storage.
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2.2.2. Purification of 2X ERE-TK-LUC plasmid from bacteria
Cultivation of bacteria Escherichia coli
2X ERE-TK-LUC reporter plasmid, which would be further used in transactivation assays, was
purified from previously transformed bacteria Escherichia coli. Therefore, the first requirement was
to grow an overnight suspension culture of E. coli that would be used for plasmid DNA
purification. For this purpose, 50 ml of previously prepared Luria Bertani medium supplemented
with 0,05 ml of ampicilin was added into 2 Erlenmeyer flasks. E. coli glycerol stock was taken out
of the –80 °C freezer and thawed at room temperature. When thawed, 20 μl of bacterial aliquot was
added into each Erlenmeyer flask. Bacterial culture was grown over the night (ca. 15 hours) in the
shaker incubator.
The next morning, optical density of E.coli overnight culture was measured in order to estimate
growth and metabolic activity of the cells. Optical density was measured at the spectrophotometer
at wavelength of 690 nm and pure LB was used as a reference sample. Since measured values of
bacterial optical density were above 0.6, bacterial cultures were transferred from incubator into the
refrigerator at 6 °C until plasmid purification.
Plasmid DNA Purification using QIAGEN Plasmid Plus Midi Kit
2X ERE-TK-LUC plasmid was purified using QIAGEN Plasmid Plus Midi Kit high-yield protocol
which will be further described. Firstly, bacterial suspensions were transferred from Erlenmeyer
flasks into NalgeneTM centrifuge tubes and centrifuged in a high speed centrifuge at 6000 x g and 4
°C for 15 minutes. Following centrifugation, supernatant was discarded and pelleted bacteria were
resuspended in the first lysis buffer, named Buffer P1. After that, 4 ml of Buffer P2 was added and
the suspension was mixed by inversion, which resulted in the appearance of homogeneous blue
coloration, and incubated at room temperature for 3 minutes. Buffer S3 was added next and the
lysate was mixed by inverting 4-6 times, so the suspension became colorless  again with visible
white precipitate of genomic DNA, proteins, cell debris, and SDS. Before transferring the lysate to
the QIAfilter cartridge, it was centrifuged at 4500 x g and 4 °C for 5 minutes in order to ensure
convenient filtration without clogging. Following centrifugation, the clear supernatant was poured
into the QIAfilter cartridge and the cell lysate was filtered into a new tube. 2 ml of Buffer BB was
then added to the cleared lysate and the suspension was mixed by inverting 6 times. Lysate was
further transferred to a QIAGEN Plasmid Plus Midi spin column with a tube extender attached on
the QIAvac 24 Plus vacuum manifold. Vacuum source was then switched on, causing the draw of
the solution through the QIAGEN Plasmid Plus Midi spin column after which the vacuum source
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was switched off again. After that, the tube extender was removed and the bound DNA was washed
with 0.7 ml of Buffer ETR using vacuum. Further washing of the DNA was continued with 0.7 ml
of Buffer PE, using vacuum again. In order to completely remove the residual wash buffer, the
column was then centrifuged at 10,000 x g for 1 min in a microcentrifuge. Following centrifugation,
the column was placed into a new 1.5 ml microcentrifuge tube. At the end, the bound plasmid DNA
needed to be eluted by adding 100 μl of water and centrifugation at 10,000 x g for 1 min in a
microcentrifuge. Thus obtained aqueous solution of plasmid DNA was stored in a -20°C freezer.
Determination of purified plasmid DNA concentration
Concentration of purified plasmid DNA was measured using a NanoDropTM spectrophotometer. For
this purpose, stored plasmid DNA was first taken out of -20°C freezer and thawed at room
temperature. To initialize the spectrophotometer, a blank measurement was performed using 1 μl of
clean deionized water. After that, concentration of plasmid DNA samples was measured from 1 μl
volume of the samples. Following measurement, one sample of plasmid DNA was discarded
because of very low concentration value, while the others had satisfactory concentration values and
were stored back in a -20°C freezer. The next step would be to verify purified DNA on gel
electrophoresis. This was not performed, so in transactivation assays other previously purified and
verified plasmid DNA samples were used.
2.2.3. Transactivation assay
Medium change to 5% DCC-medium
The first step was medium change of cultured U2OS-ERα and U2OS-ERβ cells from 10% FCS-
medium to 5% DCC-medium in order to reduce estrogen levels in fetal calf serum. This was
performed 4 to 5 days prior to transfection.
Doxycycline addition
Doxycycline was added ca. 24 hours prior to transfection to reactivate expression of ERα and ERβ
genes, respectively. The final concentration of 100 ng/ml had been previously determined by
Monroe et al. as the appropriate (Monroe et al. 2003). For this purpose, 100 μl of doxycycline
solution [10 μg/ml] was added per each flask containing 10 ml 5% DCC-medium.
Cell seeding in 24-well plate and transfection with the reporter plasmid
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Transfection was performed according to QIAGEN´s Fast-Forward Protocol, which allows cell
seeding and transfection on the same day.
The optimal amount of cells for transfection should have been 80,000 cells per well, so for that
purpose, cells were counted in Neubauer chamber. Firstly, they were enzymatically detached from
the surface of culture flask and resuspended in 5% DCC-medium after centrifugation. 20 μl of the
prepared cell suspension was then introduced into Neubauer chamber and the cell count was
performed. Cell suspension for seeding was further prepared by diluting appropriate amount of cell
suspension in corresponding amount of 5% DCC-medium, so that 500 μl of the cell suspension was
dispensed in each well. Doxycycline, in final concentration of 100 ng/ml, was added to cell
suspension for seeding as well.
Transfection mix, consisting of serum-free medium (DMEM/F12), ATR and 2X ERE-TK-LUC
plasmid was prepared, so that its final volume was 60 μl per well. Total plasmid DNA should have
been  0.4 μg per well and the volume of plasmid depended on its concentration. Subsequently, the
appropriate volume of ATR [0.75 μl/well] was added. Thus prepared transfection mix was
incubated for 10 minutes at room temperature and then added to each well drop by drop. Plate with
seeded and transfected cells was incubated for ca. 24 hours in the incubator.
Treatment of the cells with test substances
In this work, a treatment with following substances was undertaken: DMSO, 17β-estradiol,
fulvestrant, methanol extract of Mondia whitei alone and in combination with fulvestrant and 12
different fractions of Mondia whitei extract alone and in combination with fulvestrant. Each
treatment was performed in triplicates on the 24-well plate. For this purpose, ca. 24 hours post
transfection, old medium was removed and the new medium, in which test substances had already
been mixed in the appropriate concentration, was applied on the cells in the volume of 500 μl per
well. The new medium consisted of 5% DCC-medium, doxycycline in final concentration of 100
ng/ml and a test substance in the appropriate concentration. It is important to remark that DMSO, as
a solvent for test substances, should be used in the final concentration of 0.1%, since it can have
cytotoxic effects in higher concentrations. Accordingly, concentration of the stock solutions of test
substances was equal to 1000 times their concentration in the well. After applying the treatment,
cells were incubated for ca. 24 hours in the incubator.
Luciferase assay
Approximately 22-26 hours post treatment, measurement of the luciferase enzyme luminescent
activity was performed. Firstly, cell lysate was prepared by removing the old medium using vacuum
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pump, rinsing cells twice with 500 μl unsterile PBS and addition of 100 μl 1X Lysis Buffer in each
well. Plates were further frozen at -80 °C for 30 minutes to 2 hours. After thawing plates, cells were
scraped from the bottom of wells and cell lysates was transferred into 1.5 ml Eppendorf tubes on
ice. When all the lysates had been transferred, they were incubated for 3 minutes at room
temperature and then thoroughly vortexed. Each thus prepared sample was then pipetted in
duplicates into white 96-well plate, in the volume of 10 μl per well. After that, 50 μl of Luciferase
Assay Reagent was added in each well and the produced luminescence was measured at the
microplate photometer.
BCA protein assay
Bicinchoninic acid (BCA) protein assay was performed in order to determine total protein
concentration in the samples. The assay is based on reduction of Cu2+ to Cu1+ by protein in an
alkaline medium and  colorimetric detection of the cuprous cation (Cu1+) by bicinchoninic acid.
Bovine serum albumin (BSA) in 0.9% sodium chloride (saline) solution was used as reference
standards. Standards covered the range of concentrations from 0 mg/ml to 1 mg/ml and were
prepared by diluting BSA stock solution [1 mg/ml] in appropriate amount of  0.9% saline solution.
1X Lysis Buffer was used as blank. All the standards, blank and all the samples were pipetted in
triplicates into transparent 96-well plates, in the volume of 10 μl per well. After that, BCA working
reagent was prepared by mixing 50 parts of reagent containing bicinchoninic acid with 1 part of 4%
CuSO4 x 5 H2O until the solution was uniform light green color. 250 μl of thus prepared solution
was then added into each well and plates were shortly put on a plate shaker to mix each well
thoroughly. Plates were further incubated with a lid for 30 minutes in the incubator at 37 °C.
Following incubation, absorbance at 560 nm was measured at the microplate photometer.
Calculation of relative luciferase activity and statistical analysis
In order to calculate relative luciferase activity, the measured luminescence per 10 μl was
extrapolated to luminescence per 1 ml which was then divided by protein concentration [mg/ml].
Triplicate values [RLU/mg protein] for each treatment group (three wells treated with the same test
substance) were then averaged. Value of DMSO treatment was set up as 100% and values of all
other treatments were set relative to DMSO in order to obtain relative luciferase activity [%
RLU/mg protein]. Described calculation was performed using Open Office.
Statistical analysis, which included one-way ANOVA and Tukey´s test, was performed using
Origin software application in order to determine statistical significance of the obtained results.
Analysis took in account mean values of three independent experiments and the results were
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